二尖瓣手术中预防性三尖瓣成形术治疗轻中度功能性三尖瓣反流的中期随机试验结果
5年随访时,TVP-组有10例三尖瓣反流超过轻度,TVP+组无此情况(P<0.01);但两组最大氧摄取量、右心室尺寸及功能(包括心脏磁共振指标)均相似。结论认为预防性三尖瓣成形减少了中重度功能性三尖瓣反流复发并降低肺动脉压,但未改善功能容量及右心室重构。
要点
- 二尖瓣手术时预防性三尖瓣成形可减少5年随访时中重度功能性三尖瓣反流复发。
- 预防性三尖瓣成形未改善最大氧摄取量、右心室尺寸及功能。
- 该研究支持对轻中度以下功能性三尖瓣反流行预防性成形,但功能获益不明确。
核心结论
- 预防性三尖瓣成形(无论瓣环是否扩张)减少了5年随访时中重度功能性三尖瓣反流复发并降低肺动脉压,但功能容量、右心室功能及尺寸保持相似。
主要发现
- 5年随访时,TVP-组有10例三尖瓣反流超过轻度,TVP+组无此情况(P<0.01)。
- 两组最大氧摄取量、右心室基底直径、舒张末直径、收缩末直径及面积变化率相似。
- 心脏磁共振证实两组右心室舒张末容积、收缩末容积及射血分数无差异。
关键数值与推荐
- 主要终点为无三尖瓣反流≥中度且缩流颈≥4 mm。
- 次要终点包括最大氧摄取量及右心室尺寸和功能。
临床怎么用
- 对于接受二尖瓣手术的轻中度以下功能性三尖瓣反流患者,可考虑预防性三尖瓣成形以减少反流复发,但需权衡功能获益不明确。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: The optimal management of functional tricuspid regurgitation (FTR) in the setting of mitral valve operations remains controversial. The current practice is both centre specific and surgeon specific with guidelines based on non-randomized data. A prospective randomized trial was performed to evaluate the worth of less-than-severe FTR repair during mitral valve procedures. METHODS: A single-centre randomized study was designed to allocate patients with less-than-severe FTR undergoing mitral valve surgery to be prophylactically treated with or without tricuspid valve annuloplasty (TVP- or TVP+). These patients were analysed using longitudinal cardiopulmonary exercise capacity, echocardiographic follow-up and cardiac magnetic resonance. The primary outcome was freedom from more than or equal to moderate tricuspid regurgitation with vena contracta ≥4 mm. Secondary outcomes were maximal oxygen uptake and right ventricular (RV) dimension and function. RESULTS: A total of 53 patients were allocated to receive concomitant TVP+, and 53 patients were treated conservatively (TVP-). At 5 years, tricuspid regurgitation was observed to be greater than mild in 10 patients in the TVP- group and no patients in the TVP+ group (P < 0.01). Maximal oxygen uptake, RV basal diameter, end-diastolic diameter and end-systolic diameter and fractional area changes were similar in both groups. Cardiac magnetic resonance confirmed no differences in RV end-diastolic volume, RV end-systolic volume and RV ejection fraction. CONCLUSIONS: This single-centre prospective randomized trial demonstrated that prophylactic tricuspid annuloplasty irrespective of annular dilatation at the time of mitral surgery reduced the recurrence of moderate or severe FTR at 5-year follow-up and reduced the pulmonary pressure. Nevertheless, the functional capacity, the RV function and the RV dimension remained similar.
引用
- Pettinari M, De Kerchove L, Lazam S, et al. Mid-term results of a randomized trial of tricuspid annuloplasty for less-than-severe functional tricuspid regurgitation at the time of mitral valve surgery†. Eur J Cardiothorac Surg. 2019. PMID: 30517622. doi:10.1093/ejcts/ezy378
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。